ClinConnect ClinConnect Logo
Search / Trial NCT04300075

The CUSA Clarity Bone Tip Study

Launched by INTEGRA LIFESCIENCES CORPORATION · Mar 6, 2020

Trial Information

Current as of August 28, 2025

Withdrawn

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subject is at least 18 years of age
  • Subject requires a cranial skull base procedure involving removal of bone with ultrasonic aspirator
  • Subject is an appropriate candidate to receive use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery, per the study surgeon
  • Subject signed the IRB/EC-approved informed consent form demonstrating that the subject is willing and able to participate in this clinical study and to comply with all study procedures
  • Exclusion Criteria:
  • Subject is currently pregnant or plans to become pregnant prior to the study index surgery
  • Subject has any significant medical condition that in the opinion of the investigator will interfere with protocol evaluation and participation
  • Subject's surgical plan includes utilizing CUSA Clarity Bone Tip for bone removal anywhere besides the cranial skull base in an open craniotomy (e.g. transsphenoidal approach or spinal procedures).
  • Subject is a prisoner or member of a different vulnerable population that should not be included in the study per the investigator or ethics committee.
  • Intra-operative exclusion criteria :
  • Surgeon does not utilize CUSA Clarity Bone Tip for cranial skull base bone removal during surgery or utilizes CUSA Clarity Bone Tip anywhere else besides the cranial skull base

About Integra Lifesciences Corporation

Integra LifeSciences Corporation is a leading global medical technology company specializing in regenerative medicine and neurosurgery. With a commitment to innovation and excellence, Integra develops a diverse range of advanced technologies and products designed to improve patient outcomes in areas such as tissue regeneration, surgical reconstruction, and advanced wound care. The company is dedicated to supporting healthcare professionals through clinical trials that aim to validate the safety and efficacy of its cutting-edge solutions, ultimately enhancing the quality of care for patients worldwide. Integra’s focus on research and development, coupled with its robust portfolio, positions it as a key player in the medical device industry.

Locations

Udine, , Italy

Treviso, , Italy

Hamm, , Germany

Münster, , Germany

Athens, , Greece

Bari, , Italy

Patients applied

0 patients applied

Trial Officials

Jason Marzuola

Study Director

Integra LifeSciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials